Skip to content

Prognosis of Simultaneous Transurethral Resection of Bladder Tumor and Prostate and Simple TURBT in Patients with NMIBC and BPH: A Prospective Comparison Study

Prognosis of Simultaneous Transurethral Resection of Bladder Tumor and Prostate and Simple TURBT in Patients with NMIBC and BPH : A Prospective Comparison Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027176
Enrollment
Unknown
Registered
2019-11-03
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-muscle invasive bladder cancer,NMIBC

Interventions

Experimental group:Accept the simultaneous transurethral resection of bladder tumor(TURBT) and benign prostatic hyperplasia (TURP)
Control Group:Only accept the transurethral resection of bladder tumor(TURBT)

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with painless gross hematuria and urinary irritation symptoms or urinary retention. Imagining examinations and rectal digital examination prove the diagnosis of NMIBC and BPH. The outcomes of urinary cytology and urodynamics should be finished before the surgery.And all the patients must understand and sign the informed consent

Exclusion criteria

Exclusion criteria: 1. Patients have surgical contraindications or could not undergo radical surgery to obtain pathology outcome; 2. Patients proven with the invasive bladder cancer or carcinoma in situ and with the abnormally high PSA(>4) or diagnosed prostate cancer by prostate biopsy.

Design outcomes

Primary

MeasureTime frame
recurrence of the NMIBC;

Secondary

MeasureTime frame
incidence of the urinary tract infection;

Countries

China

Contacts

Public ContactJian Lin

Peking University First Hospital

linjianbj@163.com+86 13801358465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026